23andMe Launches New Genetic Report on Osteoporosis
SUNNYVALE, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics company with a mission to help ...
telecareaware.com16h
23andMe running low on cash, considers sale, “strategic alternatives” by Special Committee
The latest unsurprising development in 23andMe’s story is the admission, by their new board of directors, that 23andMe now does not have enough cash to continue for the next 12 months. They are now ...
BioPharma Dive21h
23andMe considers a sale as cash runs low
The testing company ended last year with $79 million and told investors it will need to raise money to fund its operations ...